- Home
- JOB vs MEIP Comparison
JOB vs MEIP Comparison
Compare JOB & MEIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- MEIP
- Stock Information
- Founded
- JOB 1893
- MEIP 2000
- Country
- JOB United States
- MEIP United States
- Employees
- JOB N/A
- MEIP N/A
- Industry
- JOB Diversified Commercial Services
- MEIP Biotechnology: Pharmaceutical Preparations
- Sector
- JOB Consumer Discretionary
- MEIP Health Care
- Exchange
- JOB Nasdaq
- MEIP Nasdaq
- Market Cap
- JOB 20.8M
- MEIP 17.1M
- IPO Year
- JOB N/A
- MEIP 2003
- Fundamental
- Price
- JOB $0.18
- MEIP $1.97
- Analyst Decision
- JOB
- MEIP Hold
- Analyst Count
- JOB 0
- MEIP 2
- Target Price
- JOB N/A
- MEIP $7.00
- AVG Volume (30 Days)
- JOB 211.8K
- MEIP 11.6K
- Earning Date
- JOB 05-14-2025
- MEIP 05-08-2025
- Dividend Yield
- JOB N/A
- MEIP N/A
- EPS Growth
- JOB N/A
- MEIP N/A
- EPS
- JOB N/A
- MEIP N/A
- Revenue
- JOB $111,878,000.00
- MEIP N/A
- Revenue This Year
- JOB $43.94
- MEIP N/A
- Revenue Next Year
- JOB N/A
- MEIP N/A
- P/E Ratio
- JOB N/A
- MEIP N/A
- Revenue Growth
- JOB N/A
- MEIP 33.76
- 52 Week Low
- JOB $0.18
- MEIP $1.46
- 52 Week High
- JOB $0.51
- MEIP $4.10
- Technical
- Relative Strength Index (RSI)
- JOB 37.31
- MEIP 36.87
- Support Level
- JOB $0.18
- MEIP $1.46
- Resistance Level
- JOB $0.21
- MEIP $2.35
- Average True Range (ATR)
- JOB 0.01
- MEIP 0.17
- MACD
- JOB -0.00
- MEIP 0.01
- Stochastic Oscillator
- JOB 0.00
- MEIP 60.71
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About MEIP MEI Pharma Inc.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.